应用CRISPR技术治疗人类疹病毒感染:一个范围审查
Chloë Hanssens1, Jolien Van Cleemput1
1Laboratory of Virology, Department of Translational Physiology, Infectiology and Public Health, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium.
Pathogens (Basel, Switzerland)
|July 30, 2025
概括
基于CRISPR的疗法显示出治疗疹病毒感染的希望,通过向病毒复制和潜伏. 需要进一步的研究来解决临床使用的输送和安全性.
科学领域:
- 分子生物学分子生物学
- 病毒学 病毒学
- 生物技术是生物技术.
背景情况:
- 人类疹病毒是普遍存在的双链DNA病毒,具有临床和潜伏阶段.
- 感染会导致各种各样的临床表现,特别是在免疫受损的个体中.
- 目前的抗病毒药物与潜在的感染和新出现的耐药性作斗争,需要新的治疗方法.
研究的目的:
- 对基于CRISPR的抗病毒策略对疹病毒感染进行范围审查.
- 总结机制,研究设计,成果和实施挑战.
- 突出CRISPR技术在打击疹病毒方面的潜力.
主要方法:
- 在PubMed和Web of Science进行了全面的文献搜索.
- 搜索策略包括一般术语和特定病毒的方法.
- 该审查重点关注基于CRISPR的治疗方法的体外和体内研究.
主要成果:
- 针对疹病毒的五种主要的CRISPR机制被确定.
- 策略包括抑制Lytic复制,消除潜伏的基因组,并防止重新激活.
- 克里斯普还可以诱导免疫治疗的重新激活或增强现有治疗方法.
结论:
- 基于CRISPR的策略在临床前研究中显示出对疹病毒的巨大潜力.
- 克里斯普尔系统的传递方法和生物安全性需要进一步调查.
- 优化治疗时间对于成功的临床转换至关重要.
相关概念视频
CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K
CRISPR/Cas9 Genome Editing
252
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
252
The Antiviral System of Bacteria and Archaea: CRISPR
127
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
127
Homologous Recombination
52.2K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
52.2K
CRISPR and crRNAs
17.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.4K


